US3853472A - Diagnostic test strip for the detection of components of body fluids - Google Patents
Diagnostic test strip for the detection of components of body fluids Download PDFInfo
- Publication number
- US3853472A US3853472A US00376248A US37624873A US3853472A US 3853472 A US3853472 A US 3853472A US 00376248 A US00376248 A US 00376248A US 37624873 A US37624873 A US 37624873A US 3853472 A US3853472 A US 3853472A
- Authority
- US
- United States
- Prior art keywords
- test strip
- quinoline
- compound
- test
- benzo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 210000001124 body fluid Anatomy 0.000 title claims abstract description 18
- 239000010839 body fluid Substances 0.000 title claims abstract description 18
- 238000001514 detection method Methods 0.000 title claims description 17
- 238000002405 diagnostic procedure Methods 0.000 title description 2
- 238000012360 testing method Methods 0.000 claims abstract description 89
- 150000001875 compounds Chemical class 0.000 claims abstract description 36
- 239000012190 activator Substances 0.000 claims abstract description 18
- 210000004369 blood Anatomy 0.000 claims abstract description 18
- 239000008280 blood Substances 0.000 claims abstract description 18
- 239000013543 active substance Substances 0.000 claims abstract description 14
- -1 alkyl radicals Chemical class 0.000 claims abstract description 13
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims abstract description 10
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000003153 chemical reaction reagent Substances 0.000 claims description 17
- OZKOMUDCMCEDTM-UHFFFAOYSA-N 1,7-phenanthroline Chemical compound C1=CC=C2C3=NC=CC=C3C=CC2=N1 OZKOMUDCMCEDTM-UHFFFAOYSA-N 0.000 claims description 13
- RDOWQLZANAYVLL-UHFFFAOYSA-N phenanthridine Chemical compound C1=CC=C2C3=CC=CC=C3C=NC2=C1 RDOWQLZANAYVLL-UHFFFAOYSA-N 0.000 claims description 12
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 8
- YEELFSTYCPPLQY-UHFFFAOYSA-N benzo[lmn]phenanthridine Chemical group C1=CC=C2N=CC3=CC=CC4=CC=C1C2=C43 YEELFSTYCPPLQY-UHFFFAOYSA-N 0.000 claims description 7
- HCAUQPZEWLULFJ-UHFFFAOYSA-N benzo[f]quinoline Chemical compound C1=CC=C2C3=CC=CC=C3C=CC2=N1 HCAUQPZEWLULFJ-UHFFFAOYSA-N 0.000 claims description 6
- 239000000872 buffer Substances 0.000 claims description 6
- RIYPENPUNLHEBK-UHFFFAOYSA-N phenanthro[9,10-b]pyridine Chemical compound C1=CC=C2C3=CC=CC=C3C3=CC=CC=C3C2=N1 RIYPENPUNLHEBK-UHFFFAOYSA-N 0.000 claims description 6
- DATYUTWESAKQQM-UHFFFAOYSA-N 4,7-phenanthroline Chemical compound C1=CC=C2C3=CC=CN=C3C=CC2=N1 DATYUTWESAKQQM-UHFFFAOYSA-N 0.000 claims description 5
- 239000000080 wetting agent Substances 0.000 claims description 5
- 239000002250 absorbent Substances 0.000 claims description 4
- 230000002745 absorbent Effects 0.000 claims description 4
- LOLQOGZQULMGDU-UHFFFAOYSA-N benzo[a]phenanthridine Chemical group C1=CC=CC2=C3C4=CC=CC=C4C=CC3=NC=C21 LOLQOGZQULMGDU-UHFFFAOYSA-N 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- 239000002562 thickening agent Substances 0.000 claims description 4
- RFQDDXWZZVRLKO-UHFFFAOYSA-N benzo[g]quinoline Chemical compound N1=CC=CC2=CC3=CC=CC=C3C=C21 RFQDDXWZZVRLKO-UHFFFAOYSA-N 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- GDISDVBCNPLSDU-UHFFFAOYSA-N pyrido[2,3-g]quinoline Chemical compound C1=CC=NC2=CC3=CC=CN=C3C=C21 GDISDVBCNPLSDU-UHFFFAOYSA-N 0.000 claims description 2
- XJEDMWZLWOWOSZ-UHFFFAOYSA-N 2-methylphenanthridine Chemical group C1=CC=C2C3=CC(C)=CC=C3N=CC2=C1 XJEDMWZLWOWOSZ-UHFFFAOYSA-N 0.000 claims 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical group C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 abstract description 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract description 5
- 229910052757 nitrogen Inorganic materials 0.000 abstract description 5
- 150000001491 aromatic compounds Chemical class 0.000 abstract description 4
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical group [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract description 3
- 239000000243 solution Substances 0.000 description 22
- 239000000123 paper Substances 0.000 description 14
- 230000035945 sensitivity Effects 0.000 description 13
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 9
- 210000002700 urine Anatomy 0.000 description 9
- 210000003743 erythrocyte Anatomy 0.000 description 7
- 102000001554 Hemoglobins Human genes 0.000 description 6
- 108010054147 Hemoglobins Proteins 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 238000005470 impregnation Methods 0.000 description 5
- 210000000265 leukocyte Anatomy 0.000 description 5
- NUIURNJTPRWVAP-UHFFFAOYSA-N 3,3'-Dimethylbenzidine Chemical compound C1=C(N)C(C)=CC(C=2C=C(C)C(N)=CC=2)=C1 NUIURNJTPRWVAP-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 4
- 239000001836 Dioctyl sodium sulphosuccinate Substances 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 102000036675 Myoglobin Human genes 0.000 description 3
- 108010062374 Myoglobin Proteins 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 3
- 238000007598 dipping method Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 150000002432 hydroperoxides Chemical class 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 3
- SUHRSZJZYUCLOD-UHFFFAOYSA-N 3-methylbenzo[f]quinoline Chemical compound C1=CC=C2C3=CC=C(C)N=C3C=CC2=C1 SUHRSZJZYUCLOD-UHFFFAOYSA-N 0.000 description 2
- WXMQHPKQCPCDQO-UHFFFAOYSA-N 4-dimorpholin-4-ylphosphorylmorpholine Chemical compound C1COCCN1P(N1CCOCC1)(=O)N1CCOCC1 WXMQHPKQCPCDQO-UHFFFAOYSA-N 0.000 description 2
- 239000001828 Gelatine Substances 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 108700020962 Peroxidase Proteins 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical compound C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 description 2
- WZJYKHNJTSNBHV-UHFFFAOYSA-N benzo[h]quinoline Chemical compound C1=CN=C2C3=CC=CC=C3C=CC2=C1 WZJYKHNJTSNBHV-UHFFFAOYSA-N 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000000306 component Substances 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229960001484 edetic acid Drugs 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 2
- 239000000057 synthetic resin Substances 0.000 description 2
- 229920003002 synthetic resin Polymers 0.000 description 2
- 210000001635 urinary tract Anatomy 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 210000004916 vomit Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- TXCVRHZUZDGWBJ-UHFFFAOYSA-N 1,3-dimethylbenzo[f]quinoline Chemical compound C1=CC=C2C3=C(C)C=C(C)N=C3C=CC2=C1 TXCVRHZUZDGWBJ-UHFFFAOYSA-N 0.000 description 1
- XJFXRVMHROUWCL-UHFFFAOYSA-N 1,7-phenanthroline Chemical compound C1=CC=C2C3=NC=CC=C3C=CC2=N1.C1=CC=C2C3=NC=CC=C3C=CC2=N1 XJFXRVMHROUWCL-UHFFFAOYSA-N 0.000 description 1
- QRGXLGFKLPGONP-UHFFFAOYSA-N 2,4-dimethylbenzo[g]quinoline Chemical compound C1=CC=CC2=CC3=NC(C)=CC(C)=C3C=C21 QRGXLGFKLPGONP-UHFFFAOYSA-N 0.000 description 1
- JGBAASVQPMTVHO-UHFFFAOYSA-N 2,5-dihydroperoxy-2,5-dimethylhexane Chemical compound OOC(C)(C)CCC(C)(C)OO JGBAASVQPMTVHO-UHFFFAOYSA-N 0.000 description 1
- CODTWXNXJPQQOB-UHFFFAOYSA-N 3,8-dimethyl-4,7-phenanthroline Chemical compound CC1=CC=C2C3=CC=C(C)N=C3C=CC2=N1 CODTWXNXJPQQOB-UHFFFAOYSA-N 0.000 description 1
- SBPULJLRZWGMEL-UHFFFAOYSA-N 3-methyl-4,7-phenanthroline Chemical compound C1=CC=C2C3=CC=C(C)N=C3C=CC2=N1 SBPULJLRZWGMEL-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- IMEXZJCXIUEUSZ-UHFFFAOYSA-N 4-methylbenzo[g]quinoline Chemical compound C1=CC=C2C=C3C(C)=CC=NC3=CC2=C1 IMEXZJCXIUEUSZ-UHFFFAOYSA-N 0.000 description 1
- IFMDPNYROKZRER-UHFFFAOYSA-N 6-methylphenanthridine Chemical compound C1=CC=C2C(C)=NC3=CC=CC=C3C2=C1 IFMDPNYROKZRER-UHFFFAOYSA-N 0.000 description 1
- KCUKWCWHAOETGF-UHFFFAOYSA-N C1=CC=CC2=NC=C3C=CC=CC3=C12.C1=CC=NC=2C=CC3=C(C12)C=CC=C3 Chemical compound C1=CC=CC2=NC=C3C=CC=CC3=C12.C1=CC=NC=2C=CC3=C(C12)C=CC=C3 KCUKWCWHAOETGF-UHFFFAOYSA-N 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000004141 Sodium laurylsulphate Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 238000001792 White test Methods 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- 239000000370 acceptor Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 description 1
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000012461 cellulose resin Substances 0.000 description 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- DMSZORWOGDLWGN-UHFFFAOYSA-N ctk1a3526 Chemical compound NP(N)(N)=O DMSZORWOGDLWGN-UHFFFAOYSA-N 0.000 description 1
- YQHLDYVWEZKEOX-UHFFFAOYSA-N cumene hydroperoxide Chemical compound OOC(C)(C)C1=CC=CC=C1 YQHLDYVWEZKEOX-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000004374 forensic analysis Methods 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- FDZZZRQASAIRJF-UHFFFAOYSA-M malachite green Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1C(C=1C=CC=CC=1)=C1C=CC(=[N+](C)C)C=C1 FDZZZRQASAIRJF-UHFFFAOYSA-M 0.000 description 1
- 229940107698 malachite green Drugs 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 229960000948 quinine Drugs 0.000 description 1
- WIONSVZCWDNLDJ-UHFFFAOYSA-N quinoline;toluene Chemical compound CC1=CC=CC=C1.N1=CC=CC2=CC=CC=C21 WIONSVZCWDNLDJ-UHFFFAOYSA-N 0.000 description 1
- 150000003248 quinolines Chemical class 0.000 description 1
- 150000005839 radical cations Chemical class 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- HFQQZARZPUDIFP-UHFFFAOYSA-M sodium;2-dodecylbenzenesulfonate Chemical compound [Na+].CCCCCCCCCCCCC1=CC=CC=C1S([O-])(=O)=O HFQQZARZPUDIFP-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000008362 succinate buffer Substances 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/28—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving peroxidase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/904—Oxidation - reduction indicators
Definitions
- Wolk Assistant Examiner-Arnold Turk Attorney, Agent, or FirmBurgess, 'Dinklage & Sprung ABSTRACT Test strips are provided for detecting even small amounts of blood or other peroxidatively active substances in body fluids; the strips comprising a carrier containing a hydroperoxide, a chromogen, and as an activator, a compound of the formula i'cdc wherein R is a hydrogen atom or a methyl radical and benzene and/or pyridine rings are fused on at least one of the positions indicated with c, (d,e), f and g, provided that two adjacent rings must not simultaneously each contain a cyclic nitrogen atom, and wherein the.
- aromatic compounds (1) apart from the positions indicated by H and R, can be substituted by lower alkyl radicals which together can also form a hydroaromatic ring.
- hemorrhages are caused, for example, by tumors, ulcers .and inflammations of the corresponding organsQFurthermore, free hemoglobin can also occur in the urine and plasma due to the influence of certain hemolytic toxins in the blood.
- Bloodand hemoglobin are peroxidateactive, i.e., they liberate oxygen from hydroperoxides and transfer it to certain acceptors. Other peroxidateactive, substances occur in leukocytes and bacteria. The detection of these substances is important for the diagnosis of diseases and infections of the kidney and urinary tract.
- Myoglobin which is also perioxidateactive, is found in the urine, for example, after a cardiac infarct. Furthermore, blood occurs especially frequently in the urine when calculi are present in the bladder or kidneys.
- Rapid tests are usually absorbent carriers, preferably papers, which have'been impregnated with all of the reagents necessary for the detection reaction. After simply dipping them into a body fluid, they show a color reaction. Because of the great importance which rapid tests have recently achieved, they have been developed in various ways for the detection of blood in body flu.- ids.
- German Pat. No. 1,242,905 describes test papers which, as activating additives, contain certain quinoline derivatives, preferably quinine. lt is certainly asserted that the sensitivity can be considerably increased with the mentioned additives but, acccording to our own investigations, it is practically impossible also to detect leukocytes and bacteria with the test strips improved in this manner.
- the instant invention provides test strips for the detection of peroxidate-active substances with a hitherto unachievably high sensitivity.
- test 5 strips comprising as the activator, an aromatic compound of the general formula:
- R is a hydrogen atom or a methyl radical and benzene and/or pyridine rings are fused on at least one of the positions indicated with c, (d,e), f and 3, provided that two adjacent rings must not simultaneously each contain a cyclic nitrogen atom, and wherein the aromatic compounds (1), apart from the positions indi cated by H and R can be substituted by lower alkyl radicals which together can also form a hydroaromatic ring.
- R is a hydrogen atom.
- R is a hydrogen atom.
- alkyl radicals there are to be understood alkyl radicals containing up to four carbon atoms and, when two alkyl radicals together form a hydroaromatic ring, 5- and 6- membered rings are preferred.
- the compounds of general formula (I) do not increase the sensitivity of peroxidases of vegetable origin, for example horseradish peroxidase, but act specifically on peroxidate-active substances of human and animal origin. It is thus possible selectively to detect leukocytes, blood and blood components and bacteria in feces or in vomit in the presence of vegetable peroxidases. In this case, myoglobin is detected with about the same degree of sensitivity as hemoglobin.
- the sensitivity of the detection reaction is increased by some of the compounds of general formula (l) to such an extent that even in urine it is possible to detect individual erythrocytes which are visible on the test paper as colored dots.
- a test paper with which it is still possible clearly to detect 5 erythrocytes per mm urine. This corresponds to a blood dilution of l:l,000,000.
- the sensitivity can be further modified by alkyl substitution; thus, for example, by means of a methyl substituent in a a-position to a cyclic nitrogen atom, the activity is somewhat reduced, whereas otherwise it usually leads to an increase of the activation.
- the sensitivity limit of a test strip which contains a weak activator for example 2, 8- dimethyl-l,7-phenanthroline, is about erythrocytes/mm urine.
- the activation agents according to the present invention can be used in amounts of about 0.05-1.0 percent, preferably of 0.2-0.5 percent, per 100 ml. impregnation solution.
- an organic hydroperoxide an oxidation indicator (chromogen), a buffer and a surface-active agent, as well as, if desired, a phosphoramide, for example phosphoric acid trimorpholide, for stabilization, as well as other conventional adjuvants.
- hydroperoxides there can be used, for example, cumol hydroperoxide or 2,5-dimethyl-hexane-2,5- dihydroperoxide, and as indicators those of the benzidine series, for example, o-tolidine, or those of the heterocyclic azines series, for example bis-(N-ethylquinol-2-one)-azine or (N-methylbenzthiazol-2-0ne)- (l-ethyl-3-phenyl-5-methyltriazol-2-one)-azine (see German Pat. No. 1,648,840).
- benzidine series for example, o-tolidine
- heterocyclic azines series for example bis-(N-ethylquinol-2-one)-azine or (N-methylbenzthiazol-2-0ne)- (l-ethyl-3-phenyl-5-methyltriazol-2-one)-azine (see German Pat. No. 1,648,840).
- the indicators can be used in amounts of from 0.05-5 g., preferably of 0.2-l .0 g., per ml. of impregnation solution.
- buffer there can be used, for example, a citrate, phosphate, phthalate or succinate buffer, the pH value and capacity being so chosen that, after dipping the test strip into a body fluid, a pH value of 4-7, preferably of 5-6, is obtained thereon.
- test strips due to the relatively large amounts of water-soluble substances present therein, could tend to bleed, it is of practical importance to add a thickening agent to the formulation, for example methyl cellulose and, in particular, gelatine, preferably in an amount of about 0.5-5 g. per I00 ml.
- a thickening agent for example methyl cellulose and, in particular, gelatine, preferably in an amount of about 0.5-5 g. per I00 ml.
- wetting agent there is preferably used a longchained organic sulphate or sulphonate, for example sodium dodecyl-benzene sulphonate, dioctyl sodium sulphosuccinate or sodium lauryl sulphate, which, as is known, stabilizes radical cations, such asoxidized otolidine.
- the wetting agents can be added to the impregnation solution in amounts of 0.5 to 5 percent, preferably of l 3 percent.
- absorbent carriers for example filter paper, cellulose or synthetic resin fleeces
- solutions of the reagents in readily volatile solvents This is preferably carried out in two separate steps. First, impregnation is carried out with a solution which contains a hydroperoxide, wetting agent, buffer and optionally a thickening agent. Thereafter, impregnation is carried out with a solution of an indicator and of an activator of general formula (I).
- test strips according to the present invention are,
- Solution 1 1.2M citrate buffer, pH 5.25 35.0 ml. ethylenediamine-tetraacetic acid, disodium salt 0.l g. dioctyl sodium sulphosuccinate 2.0 g. 2,5-dimethylhexane-2,S-dihydroperoxide (about 70%) 1.6 g. phosphoric acid trimorpholide l2.7 g. ethanol 30.0 ml. distilled water ad 100.0 ml.
- a white test paper is obtained which, upon dipping into a blood-containing urine, becomes green colored after about 5 to seconds. If the'erythrocytes are intact, then the paper is green flecked. lf hemolysis has taken place or if free hemoglobin is present in the urine, then the paper becomes uniformly green colored.
- the sensitivity is about 5 erythrocytes/mm or the corresponding amount of hemoglobin. A smaller number of intact erythrocytes can, under certain circumstances, still bring about individual green dots on the test paper. The sensitivity with regard to myoglobin corresponds to that for hemoglobin.
- Leukocytes and bacteria are also detected when intact, by flecking, or when lysed, by a uniform coloration.
- test paper obtained is about ten times less sensitive than the test papers according to Examples 1 and 2 (about 50-100 erythrocytes/mm in 3060 seconds).
- Test papers of similar sensitivity are obtained when, instead of 3-methylbenzo [f] quinoline, there is used an equimolar amount of one of the'following activators: 1,3-dimethylbenzo [f] quinoline; 2,4-dimethylbenzo [g] quinoline; 6-methylphenanthridine; 3,8-dimethyl- 4,7-phenanthroline; 2,8-dimethyl-l,7-phenanthroline; or 2,7-dimethyll ,o-anthrazoline.
- Test strip for the detection of peroxidatively-active substances in body fluids, comprising a carrier containing a hydroperoxide, at least one chromogen and, as an activator, a compound of the formula wherein R is hydrogen or methyl; and benzene and/or pyridine ririgs are fused on at least one of the positions indicated with c, (d,e), f and g, provided that two adjacent rings must not simultaneously contain a cyclic nitrogen atom, and wherein said compound can be substituted, other than in the positions indicated by H and R by lower alkyl radicals, which radicals together can also form a hydroaromatic ring.
- Test strip as claimed in claim 1, wherein the carrier is an absorbent material impregnated with the reagents.
- Test strip as claimed in claim 1, wherein the carrier is a water-stable film with the reagents incorporated therein.
- Test strip as claimed in claim 1, wherein the reagent solution used for the production thereof contains 0.2-0.5 percent of activator per 100 ml. of solution.
- Test strip as claimed in claim 1, wherein the reagent solution used for the production thereof contains 0.05-5 g. of chromogen per 100 ml. of solution.
- Test strip as claimed in claim 1, wherein the reagent solution used for the production thereof contains a buffer and or a complex former, a thickener or a wetting agent.
- Method of detecting small amounts of blood in a body fluid comprises contacting a test sample of the body fluid with a test strip as claimed in .claim 1 and observing the color formation thereon as an indication of the absence or presence of blood in said saple.
- Method of detecting small amounts of peroxidatively active substances in a body fluid comprises contacting a test sample of the body fluid with a test strip as claimed in claim 1 and observing the color formation thereon as an indication of the absence or presence of peroxidatively active substances in said sample.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2235152A DE2235152C2 (de) | 1972-07-18 | 1972-07-18 | Diagnostisches Mittel zum Nachweis von Blut und anderen peroxidatisch wirksamen Substanzen in Körperflüssigkeiten |
Publications (1)
Publication Number | Publication Date |
---|---|
US3853472A true US3853472A (en) | 1974-12-10 |
Family
ID=5850916
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US00376248A Expired - Lifetime US3853472A (en) | 1972-07-18 | 1973-07-03 | Diagnostic test strip for the detection of components of body fluids |
Country Status (19)
Cited By (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3966414A (en) * | 1974-01-16 | 1976-06-29 | Bio-Medical Sciences, Inc. | Time temperature indicators |
US3975161A (en) * | 1975-02-14 | 1976-08-17 | Lachema, Narodni Podnik | Biological diagnostic test strip |
US3986833A (en) * | 1975-09-08 | 1976-10-19 | Miles Laboratories, Inc. | Test composition, device, and method for the detection of peroxidatively active substances |
US4148611A (en) * | 1978-06-28 | 1979-04-10 | Miles Laboratories, Inc. | Test composition, device and method for the detection of peroxidatively active substances |
US4175923A (en) * | 1978-06-26 | 1979-11-27 | Friend William G | Method and apparatus for occult blood testing in the home |
EP0014929A1 (de) * | 1979-02-14 | 1980-09-03 | Roche Diagnostics GmbH | Diagnostisches Mittel, Verfahren zu dessen Herstellung sowie dessen Verwendung zum Nachweis von Leukozyten in Körperflüssigkeiten |
US4251222A (en) * | 1979-12-17 | 1981-02-17 | Miles Laboratories, Inc. | Sensitizers for peroxidative activity tests |
US4251223A (en) * | 1979-12-17 | 1981-02-17 | Miles Laboratories, Inc. | Sensitizers for peroxidative activity tests |
US4278439A (en) * | 1979-12-17 | 1981-07-14 | Miles Laboratories, Inc. | Sensitizers for peroxidative activity tests |
US4339243A (en) * | 1979-11-13 | 1982-07-13 | Miles Laboratories, Inc. | Stabilization of benzidine-type indicators with various enhancers |
US4339242A (en) * | 1979-11-13 | 1982-07-13 | Miles Laboratories, Inc. | Stabilization of benzidine-type indicators with various enhancers |
US4340395A (en) * | 1979-11-13 | 1982-07-20 | Miles Laboratories, Inc. | Stabilization of benzidine-type indicators with various enhancers |
US4340393A (en) * | 1979-11-13 | 1982-07-20 | Miles Laboratories, Inc. | Stabilization of benzidine-type indicators with various enhancers |
US4340394A (en) * | 1979-11-13 | 1982-07-20 | Miles Laboratories, Inc. | Stabilization of benzidine-type indicators with various enhancers |
US4340392A (en) * | 1979-11-13 | 1982-07-20 | Miles Laboratories, Inc. | Stabilization of benzidine-type indicators with various enhancers |
US4380585A (en) * | 1979-11-13 | 1983-04-19 | Miles Laboratories, Inc. | Stabilization of benzidine-type indicators with various enhancers |
US4388271A (en) * | 1980-01-10 | 1983-06-14 | Rohm Gmbh | Rapid diagnostic agents |
US4673654A (en) * | 1985-10-31 | 1987-06-16 | Warner-Lambert Company | Composition for determining peroxidase-like activity of hemoglobin |
US4676950A (en) * | 1984-02-03 | 1987-06-30 | Foster Research Corporation | Indicator and test device for detecting occult blood |
US4755472A (en) * | 1986-01-16 | 1988-07-05 | Miles Inc. | Stable composition for the determination of peroxidatively active substances |
US4849342A (en) * | 1985-01-31 | 1989-07-18 | Savyon Diagnostics Limited | Method for carrying out enzyme assays |
US4956300A (en) * | 1982-01-05 | 1990-09-11 | Helena Laboratories Corporation | Aid for determining the presence of occult blood, method of making the aid, and method of using the aid |
US5081040A (en) * | 1987-06-29 | 1992-01-14 | Helena Laboratories Corporation | Composition and kit for testing for occult blood in human and animal excretions, fluids, or tissue matrixes |
US5196167A (en) * | 1989-04-04 | 1993-03-23 | Helena Laboratories Corporation | Fecal occult blood test product with positive and negative controls |
US5217874A (en) * | 1989-04-04 | 1993-06-08 | Helena Laboratories Corporation | Fecal occult blood test product with positive and negative controls |
US5273888A (en) * | 1984-01-16 | 1993-12-28 | Helena Laboratories Corporation | Chemical test kit and method for determining the presence of blood in a specimen and for verifying the effectiveness of the chemicals |
US5369013A (en) * | 1987-06-22 | 1994-11-29 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Method, reagent mixture and kit for determining the presence of bacterial or somatic cells in urine |
US5426032A (en) * | 1986-08-13 | 1995-06-20 | Lifescan, Inc. | No-wipe whole blood glucose test strip |
WO1997035030A1 (en) * | 1996-03-22 | 1997-09-25 | Stc Technologies, Inc. | A solution-based assay for peroxidatively-active substances in bodily fluids |
US5702913A (en) * | 1983-12-21 | 1997-12-30 | Helena Laboratories Corporation | Chromgen-reagent test system |
US5827677A (en) * | 1996-02-01 | 1998-10-27 | Universal Lavel | Method and device for specifically detecting myoglobin using a non-discriminating peroxidase sensitive assay |
US5885789A (en) * | 1997-03-20 | 1999-03-23 | Stc Technologies Incorporated | Solution-based assay for peroxidatively-active substances in bodily fluids |
US6458326B1 (en) | 1999-11-24 | 2002-10-01 | Home Diagnostics, Inc. | Protective test strip platform |
US6525330B2 (en) | 2001-02-28 | 2003-02-25 | Home Diagnostics, Inc. | Method of strip insertion detection |
US6541266B2 (en) | 2001-02-28 | 2003-04-01 | Home Diagnostics, Inc. | Method for determining concentration of an analyte in a test strip |
US6562625B2 (en) | 2001-02-28 | 2003-05-13 | Home Diagnostics, Inc. | Distinguishing test types through spectral analysis |
US7846383B2 (en) | 2006-12-15 | 2010-12-07 | Kimberly-Clark Worldwide, Inc. | Lateral flow assay device and absorbent article containing same |
US8012761B2 (en) | 2006-12-14 | 2011-09-06 | Kimberly-Clark Worldwide, Inc. | Detection of formaldehyde in urine samples |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2436598C2 (de) * | 1974-07-30 | 1983-04-07 | Boehringer Mannheim Gmbh, 6800 Mannheim | Stabiler Teststreifen zum Nachweis von Inhaltsstoffen in Flüssigkeiten |
DE2716060C3 (de) * | 1977-04-09 | 1980-06-12 | Boehringer Mannheim Gmbh, 6800 Mannheim | Stabilisierte Schnelldiagnostica mit Oxydationsindikatoren |
DE2926271A1 (de) * | 1979-06-29 | 1981-01-08 | Behringwerke Ag | Mittel zum nachweis peroxidatisch wirksamer substanzen |
CA1143634A (en) * | 1980-06-02 | 1983-03-29 | Alan E. Burkhardt | Interference-resistant test device for determining a peroxidately active substance in a test sample and method for preparing it |
US4672029A (en) * | 1984-12-06 | 1987-06-09 | Eastman Kodak Company | Color-forming couplers and their use in the analytical determination of hydrogen peroxide or other analytes |
EP0196743A3 (en) * | 1985-01-31 | 1988-10-19 | Savyon Diagnostics Ltd. | Stable chemical compositions containing chromogenic materials and peroxides, and method for obtaining them |
DE19500768C2 (de) * | 1994-01-17 | 2003-11-20 | Aventis Res & Tech Gmbh & Co | Phenanthren-Derivate und ihre Verwendung in flüssigkristallinen Mischungen |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3290117A (en) * | 1963-06-24 | 1966-12-06 | Miles Lab | Occult blood diagnostic composition with color enhancing agent |
US3712853A (en) * | 1969-08-14 | 1973-01-23 | Boehringer Mannheim Gmbh | Diagnostic agent for the detection of nitrite and of nitrite-forming bacteria |
-
1972
- 1972-07-18 DE DE2235152A patent/DE2235152C2/de not_active Expired
-
1973
- 1973-07-03 US US00376248A patent/US3853472A/en not_active Expired - Lifetime
- 1973-07-11 CA CA176,154A patent/CA988011A/en not_active Expired
- 1973-07-12 SE SE7309791A patent/SE388693B/xx unknown
- 1973-07-12 AR AR294043A patent/AR195135A1/es active
- 1973-07-13 NL NL737309779A patent/NL152085B/xx not_active IP Right Cessation
- 1973-07-13 IT IT26612/73A patent/IT994949B/it active
- 1973-07-13 FI FI2240/73A patent/FI53511C/fi active
- 1973-07-16 DD DD172306A patent/DD105065A5/xx unknown
- 1973-07-16 CH CH1034773A patent/CH579275A5/xx not_active IP Right Cessation
- 1973-07-16 FR FR7325947A patent/FR2198643A5/fr not_active Expired
- 1973-07-16 ZA ZA734810A patent/ZA734810B/xx unknown
- 1973-07-16 GB GB3373173A patent/GB1390900A/en not_active Expired
- 1973-07-17 AT AT628773A patent/AT326276B/de active
- 1973-07-17 HU HUBO1451A patent/HU166368B/hu unknown
- 1973-07-18 JP JP48082405A patent/JPS583680B2/ja not_active Expired
- 1973-07-18 AU AU58263/73A patent/AU468582B2/en not_active Expired
-
1978
- 1978-02-21 BE BE185336A patent/BE864154Q/xx not_active IP Right Cessation
- 1978-04-13 HK HK205/78A patent/HK20578A/xx unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3290117A (en) * | 1963-06-24 | 1966-12-06 | Miles Lab | Occult blood diagnostic composition with color enhancing agent |
US3712853A (en) * | 1969-08-14 | 1973-01-23 | Boehringer Mannheim Gmbh | Diagnostic agent for the detection of nitrite and of nitrite-forming bacteria |
Cited By (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3966414A (en) * | 1974-01-16 | 1976-06-29 | Bio-Medical Sciences, Inc. | Time temperature indicators |
US3975161A (en) * | 1975-02-14 | 1976-08-17 | Lachema, Narodni Podnik | Biological diagnostic test strip |
US3986833A (en) * | 1975-09-08 | 1976-10-19 | Miles Laboratories, Inc. | Test composition, device, and method for the detection of peroxidatively active substances |
JPS5233594A (en) * | 1975-09-08 | 1977-03-14 | Miles Lab | Testing constitutes* instruments and methods for detection of peroxidation active substances |
US4175923A (en) * | 1978-06-26 | 1979-11-27 | Friend William G | Method and apparatus for occult blood testing in the home |
US4148611A (en) * | 1978-06-28 | 1979-04-10 | Miles Laboratories, Inc. | Test composition, device and method for the detection of peroxidatively active substances |
US4299917A (en) * | 1979-02-14 | 1981-11-10 | Boehringer Manneheim Gmbh | Diagnostic agents for the detection of leukocytes in body fluids |
EP0014929A1 (de) * | 1979-02-14 | 1980-09-03 | Roche Diagnostics GmbH | Diagnostisches Mittel, Verfahren zu dessen Herstellung sowie dessen Verwendung zum Nachweis von Leukozyten in Körperflüssigkeiten |
US4339243A (en) * | 1979-11-13 | 1982-07-13 | Miles Laboratories, Inc. | Stabilization of benzidine-type indicators with various enhancers |
US4380585A (en) * | 1979-11-13 | 1983-04-19 | Miles Laboratories, Inc. | Stabilization of benzidine-type indicators with various enhancers |
US4340392A (en) * | 1979-11-13 | 1982-07-20 | Miles Laboratories, Inc. | Stabilization of benzidine-type indicators with various enhancers |
US4340394A (en) * | 1979-11-13 | 1982-07-20 | Miles Laboratories, Inc. | Stabilization of benzidine-type indicators with various enhancers |
US4340393A (en) * | 1979-11-13 | 1982-07-20 | Miles Laboratories, Inc. | Stabilization of benzidine-type indicators with various enhancers |
US4339242A (en) * | 1979-11-13 | 1982-07-13 | Miles Laboratories, Inc. | Stabilization of benzidine-type indicators with various enhancers |
US4340395A (en) * | 1979-11-13 | 1982-07-20 | Miles Laboratories, Inc. | Stabilization of benzidine-type indicators with various enhancers |
US4251223A (en) * | 1979-12-17 | 1981-02-17 | Miles Laboratories, Inc. | Sensitizers for peroxidative activity tests |
US4278439A (en) * | 1979-12-17 | 1981-07-14 | Miles Laboratories, Inc. | Sensitizers for peroxidative activity tests |
EP0030682A1 (en) * | 1979-12-17 | 1981-06-24 | Miles Laboratories, Inc. | Test composition for peroxidatively active substances, test device containing the composition, process for preparing same and method for the determination of peroxidatively active substances |
US4251222A (en) * | 1979-12-17 | 1981-02-17 | Miles Laboratories, Inc. | Sensitizers for peroxidative activity tests |
US4388271A (en) * | 1980-01-10 | 1983-06-14 | Rohm Gmbh | Rapid diagnostic agents |
US4956300A (en) * | 1982-01-05 | 1990-09-11 | Helena Laboratories Corporation | Aid for determining the presence of occult blood, method of making the aid, and method of using the aid |
US5702913A (en) * | 1983-12-21 | 1997-12-30 | Helena Laboratories Corporation | Chromgen-reagent test system |
US5273888A (en) * | 1984-01-16 | 1993-12-28 | Helena Laboratories Corporation | Chemical test kit and method for determining the presence of blood in a specimen and for verifying the effectiveness of the chemicals |
US4676950A (en) * | 1984-02-03 | 1987-06-30 | Foster Research Corporation | Indicator and test device for detecting occult blood |
US4849342A (en) * | 1985-01-31 | 1989-07-18 | Savyon Diagnostics Limited | Method for carrying out enzyme assays |
US4673654A (en) * | 1985-10-31 | 1987-06-16 | Warner-Lambert Company | Composition for determining peroxidase-like activity of hemoglobin |
US4755472A (en) * | 1986-01-16 | 1988-07-05 | Miles Inc. | Stable composition for the determination of peroxidatively active substances |
US6268162B1 (en) | 1986-08-13 | 2001-07-31 | Lifescan, Inc. | Reflectance measurement of analyte concentration with automatic initiation of timing |
US6858401B2 (en) | 1986-08-13 | 2005-02-22 | Lifescan, Inc. | Minimum procedure system for the determination of analytes |
US6887426B2 (en) | 1986-08-13 | 2005-05-03 | Roger Phillips | Reagents test strip adapted for receiving an unmeasured sample while in use in an apparatus |
US5426032A (en) * | 1986-08-13 | 1995-06-20 | Lifescan, Inc. | No-wipe whole blood glucose test strip |
US5563042A (en) * | 1986-08-13 | 1996-10-08 | Lifescan, Inc. | Whole blood glucose test strip |
US6881550B2 (en) | 1986-08-13 | 2005-04-19 | Roger Phillips | Method for the determination of glucose employing an apparatus emplaced matrix |
US6821483B2 (en) | 1986-08-13 | 2004-11-23 | Lifescan, Inc. | Reagents test strip with alignment notch |
US5843692A (en) * | 1986-08-13 | 1998-12-01 | Lifescan, Inc. | Automatic initiation of a time interval for measuring glucose concentration in a sample of whole blood |
US5369013A (en) * | 1987-06-22 | 1994-11-29 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Method, reagent mixture and kit for determining the presence of bacterial or somatic cells in urine |
US5081040A (en) * | 1987-06-29 | 1992-01-14 | Helena Laboratories Corporation | Composition and kit for testing for occult blood in human and animal excretions, fluids, or tissue matrixes |
US5217874A (en) * | 1989-04-04 | 1993-06-08 | Helena Laboratories Corporation | Fecal occult blood test product with positive and negative controls |
US5196167A (en) * | 1989-04-04 | 1993-03-23 | Helena Laboratories Corporation | Fecal occult blood test product with positive and negative controls |
US5827677A (en) * | 1996-02-01 | 1998-10-27 | Universal Lavel | Method and device for specifically detecting myoglobin using a non-discriminating peroxidase sensitive assay |
WO1997035030A1 (en) * | 1996-03-22 | 1997-09-25 | Stc Technologies, Inc. | A solution-based assay for peroxidatively-active substances in bodily fluids |
US5885789A (en) * | 1997-03-20 | 1999-03-23 | Stc Technologies Incorporated | Solution-based assay for peroxidatively-active substances in bodily fluids |
US6458326B1 (en) | 1999-11-24 | 2002-10-01 | Home Diagnostics, Inc. | Protective test strip platform |
US6979571B2 (en) | 1999-11-24 | 2005-12-27 | Home Diagnostics, Inc. | Method of using a protective test strip platform for optical meter apparatus |
US6525330B2 (en) | 2001-02-28 | 2003-02-25 | Home Diagnostics, Inc. | Method of strip insertion detection |
US6562625B2 (en) | 2001-02-28 | 2003-05-13 | Home Diagnostics, Inc. | Distinguishing test types through spectral analysis |
US6541266B2 (en) | 2001-02-28 | 2003-04-01 | Home Diagnostics, Inc. | Method for determining concentration of an analyte in a test strip |
US7390665B2 (en) | 2001-02-28 | 2008-06-24 | Gilmour Steven B | Distinguishing test types through spectral analysis |
US8012761B2 (en) | 2006-12-14 | 2011-09-06 | Kimberly-Clark Worldwide, Inc. | Detection of formaldehyde in urine samples |
US7846383B2 (en) | 2006-12-15 | 2010-12-07 | Kimberly-Clark Worldwide, Inc. | Lateral flow assay device and absorbent article containing same |
Also Published As
Publication number | Publication date |
---|---|
FR2198643A5 (enrdf_load_stackoverflow) | 1974-03-29 |
AR195135A1 (es) | 1973-09-10 |
DE2235152A1 (enrdf_load_stackoverflow) | 1974-01-10 |
SE388693B (sv) | 1976-10-11 |
DE2235152B1 (de) | 1974-01-10 |
ATA628773A (de) | 1975-02-15 |
HU166368B (enrdf_load_stackoverflow) | 1975-03-28 |
AU5826373A (en) | 1975-01-23 |
BE864154Q (fr) | 1978-08-21 |
NL7309779A (enrdf_load_stackoverflow) | 1974-01-22 |
JPS4954094A (enrdf_load_stackoverflow) | 1974-05-25 |
JPS583680B2 (ja) | 1983-01-22 |
CH579275A5 (enrdf_load_stackoverflow) | 1976-08-31 |
NL152085B (nl) | 1977-01-17 |
AT326276B (de) | 1975-12-10 |
CA988011A (en) | 1976-04-27 |
DE2235152C2 (de) | 1975-07-10 |
FI53511C (fi) | 1978-05-10 |
ZA734810B (en) | 1974-07-31 |
HK20578A (en) | 1978-04-20 |
DD105065A5 (enrdf_load_stackoverflow) | 1974-04-05 |
IT994949B (it) | 1975-10-20 |
AU468582B2 (en) | 1976-01-15 |
FI53511B (enrdf_load_stackoverflow) | 1978-01-31 |
GB1390900A (en) | 1975-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3853472A (en) | Diagnostic test strip for the detection of components of body fluids | |
US3917452A (en) | Diagnostic agent for the detection of peroxidatively active substances | |
US3853471A (en) | Diagnostic composition for the detection of peroxidatively active substances in body fluids | |
US3986833A (en) | Test composition, device, and method for the detection of peroxidatively active substances | |
CA1045012A (en) | Diagnostic test strips | |
US4278439A (en) | Sensitizers for peroxidative activity tests | |
US5362633A (en) | Method of assaying for peroxidatively active substances | |
DE3851265T2 (de) | Hydrolysierbare Verbindungen, die elektronübertragende Mittel freigeben und ihre analytische Verwendung. | |
EP0190740A2 (en) | Use of substituted quinone electron transfer agents in analytical determinations | |
US4251223A (en) | Sensitizers for peroxidative activity tests | |
GB1065526A (en) | Diagnostic compositions and test indicators | |
US3880588A (en) | Diagnostic agent for detecting bilirubin | |
US4251222A (en) | Sensitizers for peroxidative activity tests | |
EP0158964B1 (en) | Tester for detecting a substance in a body fluid | |
EP0141244B1 (en) | Testing agent for detecting a subtance in a body fluid | |
US4481295A (en) | Substituted or condensed pyridines in a process for the detection of substances having a peroxidatic effect and a diagnostic agent containing such pyridines | |
EP0255679B1 (en) | Composition and method using substituted ortho-quinones as electron transfer agents in analytical determinations | |
EP0118274A1 (en) | Microbiological test processes | |
US4879243A (en) | Use of substituted ortho-quinones as electron transfer agents in analytical determinations | |
US4670402A (en) | Use of benzimidazole derivatives for the detection of blood and other peroxidatically active substances in body fluids and excretion products | |
GB1560077A (en) | Test composition for the detection or peroxidatively active substances | |
EP0259133A2 (en) | Use of organic buffers to reduce dehydroascorbic acid interference in analytical methods | |
US3072539A (en) | Diagnostic composition for detecting glucose | |
JPH02232561A (ja) | 新規な潜血検出用試験片。 | |
JPS6318703B2 (enrdf_load_stackoverflow) |